Karin Jennbacken - Concepedia

Concepedia

Author

Karin Jennbacken

University of Gothenburg ORCID

Also Known As

K J Jennbacken, K Jennbacken, K. Jennbacken, Karin Jennbacken

49

Publications

1.3K

Citations

23

H-Index

46

Concepts

All Affiliations

University of Gothenburg AstraZeneca (Sweden)Sahlgrenska University Hospital Karolinska Institutet AstraZeneca (United Kingdom)

KJ

About

Karin Jennbacken is an author at University of Gothenburg specializing in medicine, cell biology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	332
2	Cell Biology	5	5	309
3	Engineering	1	1	76
4	Biomedical Engineering	1	1	76
5	Cellular Physiology	1	1	39

Karin Jennbacken

×

27

Publications

1.3K

Citations

23

H-Index

	Year	Citations
Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine Leif Carlsson, Jonathan Clarke, Christopher Yen, Molecular Therapy — Methods & Clinical Development	2018	167
Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis Karin Jennbacken, Christina Vallbo, Wanzhong Wang, The Prostate	2005	132
N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer Karin Jennbacken, Tajana Tešan, Wanzhong Wang, Endocrine Related Cancer Androgen ReceptorAndrogen-deprivation TherapyUrologyOncologyGenitourinary Cancer	2010	127
Lipid Nanoparticles Deliver the Therapeutic VEGFA mRNA In Vitro and In Vivo and Transform Extracellular Vesicles for Their Functional Extensions Muhammad Nawaz, Sepideh Heydarkhan‐Hagvall, Benyapa Tangruksa, Advanced Science NanoparticlesEngineeringImmunologyLipid NanoparticlesExtracellular Microvesicles	2023	76
Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity Karin Jennbacken, Heléne Gustavsson, Karin Welén, The Prostate	2006	52
Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline‐3‐carboxamide tasquinimod (ABR‐215050) Karin Jennbacken, Karin Welén, Anders Olsson, The Prostate	2011	51
Altered expression of genes regulating angiogenesis in experimental androgen‐independent prostate cancer Heléne Gustavsson, Karin Jennbacken, Karin Welén, The Prostate	2007	48
Migratory and anti-fibrotic programmes define the regenerative potential of human cardiac progenitors Christine M Poch, Kylie S. Foo, Maria Teresa De Angelis, Nature Cell Biology	2022	45
Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang‐2 Tajana Tešan Tomić, Heléne Gustavsson, Wanzhong Wang, The Prostate	2011	44
Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts Karin Welén, Karin Jennbacken, Tajana Tešan, Prostate Cancer and Prostatic Diseases Blood VesselsUrologyProstate Cancer XenograftsPerineural InvasionGenitourinary Cancer	2008	42

Page 1